Description
Product Characteristics: For the quantitative determination of human alpha-N-acetylgalactosaminidase (NAGA) concentrations in serum, plasma, tissue homogenates, saliva, urine.
Target Information: NAGA encodes the lysosomal enzyme alpha-N-acetylgalactosaminidase, which cleaves alpha-N-acetylgalactosaminyl moieties from glycoconjugates. Mutations in NAGA have been identified as the cause of Schindler disease types I and II (type II also known as Kanzaki disease). [provided by RefSeq, Jul 2008]